Summary

Adverse reactions to latex products in the oral healthcare setting can result in potentially serious health problems. A reasonable reduction of latex products should be considered for the protection of both OHCP and the patient. Likewise, protocols to minimize the exposure of at-risk OHCP to patients who have been diagnosed with a transmissible infectious disease, and to minimize the exposure of patients to OHCP who have been exposed to or have been diagnosed with an infectious disease should be written and clearly communicated through education and training.